Home › NDC Lookup › RxCUI directory › RxCUI 1116150

Bacitracin zinc 0.4 UNT/MG / hydrocortisone acetate 0.01 MG/MG / neomycin sulfate 0.0035 M... — RxCUI 1116150

RxNorm drug concept · Semantic clinical drug
RxCUI 1116150 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1116150
Official nameBacitracin zinc 0.4 UNT/MG / hydrocortisone acetate 0.01 MG/MG / neomycin sulfate 0.0035 MG/MG / polymyxin B sulfate 10 UNT/MG Ophthalmic Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbacitracin zinc 400 UNT/GM / hydrocortisone acetate 1 % / neomycin sulfate 3.5 MG/GM / polymyxin B sulfate 10,000 UNT/GM Ophthalmic Ointment; bacitracin zinc 400 UNT / hydrocortisone acetate 10 MG / neomycin sulfate 3.5 MG / polymyxin B sulfate 10,000 UNT per GM Ophthalmic Ointment
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)856 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Neomycin, Polymyxin, Bacitracin, and Hydrocortisone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's used when your eye is both inflamed and infected — or when there's a real risk of infection. The corticosteroid (hydrocortisone) calms the inflammation and swelling, while the...
  • What exactly is this eye ointment used for?
  • Apply the ointment directly to the eye as directed by your eye doctor. Do not inject it into the eye — it's only for surface application. If you're not sure of the right technique,...
  • The most common issue is a sensitivity reaction to the antibiotic ingredient — usually showing up as itching, redness, or swelling of the eyelid or around the eye. You may also not...
📖 Read our full Neomycin, Polymyxin, Bacitracin, and Hydrocortisone Topical guide →

🕸️ Concept Web — How Bacitracin zinc 0.4 UNT/MG / hydrocortisone acet... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bacitracin zinc 0.4 UNT/MG / hydrocortisone acetate 0.01 MG/MG / neomycin sulfate 0.0035 MG/MG / polymyxin B sulfate 10 UNT/MG Ophthalmic Ointment RxCUI 1116150

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 9

    The active substance itself — no strength, form, or brand attached yet.

    • Bacitracin 1291
    • Hydrocortisone 5492
    • Neomycin 7299
    • Polymyxin B 8536
    • Bacitracin / hydrocortisone / neomycin / polymyxin B 689623
    • Bacitracin zinc 11417
    • Hydrocortisone acetate 27197
    • Neomycin sulfate 7300
    • +1 more in this family
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Neo-Polycin HC 1116151
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bacitracin / hydrocortisone / neomycin / polymyxin B Ophthalmic Ointment 374806
    • Bacitracin zinc / hydrocortisone acetate / neomycin sulfate / polymyxin B sulfate Ophthalmic Ointment 2649402
    • Bacitracin / hydrocortisone / neomycin / polymyxin B Ophthalmic Product 1155342
    • Bacitracin zinc / hydrocortisone acetate / neomycin sulfate / polymyxin B sulfate Ophthalmic Product 2660199
    • Bacitracin / hydrocortisone / neomycin / polymyxin B Ophthalmic Ointment [Neo-Polycin HC] 1116153
    • Bacitracin zinc / hydrocortisone acetate / neomycin sulfate / polymyxin B sulfate Ophthalmic Ointment [Neo-Polycin HC] 2657710
    • Neo-Polycin HC Ophthalmic Product 1181120
    • Ophthalmic Ointment 91344
    • +1 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Bacitracin zinc 0.4 UNT/MG 1093246
    • Hydrocortisone acetate 0.01 MG/MG 1013097
    • Neomycin sulfate 0.0035 MG/MG 1093247
    • Polymyxin B sulfate 10 UNT/MG 1116149
    • Bacitracin zinc 0.4 UNT/MG / hydrocortisone acetate 0.01 MG/MG / neomycin sulfate 0.0035 MG/MG / polymyxin B sulfate 10 UNT/MG Ophthalmic Ointment [Neo-Polycin HC] 1116154
    • Bacitracin zinc 0.4 UNT/MG / hydrocortisone acetate 0.01 MG/MG / neomycin sulfate 0.0035 MG/MG / polymyxin B sulfate 10 UNT/MG [Neo-Polycin HC] 1116152

Showing up to 8 concepts per family — 23 of 25 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bacitracin zinc 0.4 UNT/MG SCDC · 1093246
  • Hydrocortisone acetate 0.01 MG/MG SCDC · 1013097
  • Neomycin sulfate 0.0035 MG/MG SCDC · 1093247
  • Polymyxin B sulfate 10 UNT/MG SCDC · 1116149
  • Bacitracin / hydrocortisone / neomycin / polymyxin B Ophthalmic Ointment SCDF · 374806
  • Bacitracin zinc / hydrocortisone acetate / neomycin sulfate / polymyxin B sulfate Ophthalmic Ointment SCDFP · 2649402
  • Bacitracin / hydrocortisone / neomycin / polymyxin B Ophthalmic Product SCDG · 1155342
  • Bacitracin zinc / hydrocortisone acetate / neomycin sulfate / polymyxin B sulfate Ophthalmic Product SCDGP · 2660199

Brand-Name Concepts

  • Bacitracin zinc 0.4 UNT/MG / hydrocortisone acetate 0.01 MG/MG / neomycin sulfate 0.0035 MG/MG / polymyxin B sulfate 10 UNT/MG Ophthalmic Ointment [Neo-Polycin HC] SBD · 1116154
  • Bacitracin zinc 0.4 UNT/MG / hydrocortisone acetate 0.01 MG/MG / neomycin sulfate 0.0035 MG/MG / polymyxin B sulfate 10 UNT/MG [Neo-Polycin HC] SBDC · 1116152
  • Bacitracin / hydrocortisone / neomycin / polymyxin B Ophthalmic Ointment [Neo-Polycin HC] SBDF · 1116153
  • Bacitracin zinc / hydrocortisone acetate / neomycin sulfate / polymyxin B sulfate Ophthalmic Ointment [Neo-Polycin HC] SBDFP · 2657710
  • Neo-Polycin HC Ophthalmic Product SBDG · 1181120
  • Neo-Polycin HC BN · 1116151

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1116150 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24208-0785-55 1 TUBE in 1 CARTON (24208-785-55) / 3.5 g in 1 TUBE Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone Bausch & Lomb Incorporated 1995-10-30
Observed labelers: Bausch & Lomb Incorporated (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$5.1938
Range $5.1938–$5.1938 · middle 50% $5.1938–$5.1938 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.